With growing concern of genetic disorders and chronic conditions across the globe, the healthcare industry has necessitated the carrier screening of prenatal and newborn. Several government organizations and industrial players are focusing on strategic initiatives to enhance carrier screening of individuals to determine couples at greater risk of genetic conditions. For instance, KK Women’s and Children’s Hospital and Temasek Foundation conjointly launched Temasek Foundation PREDICT (Parenth...

The global lyophilization services market, valued at USD 3.0 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 4.7 billion by 2035, with a 4.3% CAGR during the forecast period 2026 to 2035. Antibodies market segment holds the largest share of the market and are poised to capture 52% of the overall revenue share by 2035.

The real-time location system market size is projected to grow from USD 8.17 billion in 2025 to USD 73.40 billion by 2035, representing a CAGR of 24.54% during the forecast period 2025-2035.

Recent research published by researchers at Mount Sinai in January 2025, led by Josep M. Llovet, MD, PhD, Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai have made a breakthrough in the treatment of hepatocellular carcinoma with combination approach. Under Phase III clinical study, “LEAP-012: Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma,” has show...

The global pen injectors market size, valued at USD 43.85 billion in 2024, is projected to reach USD 47.22 billion in 2025 and USD 87.19 billion by 2035, representing a CAGR of 6.3% during the forecast period. North America holds the largest share (41%), notably, Asia-Pacific is expected to see the highest growth due to increasing chronic illness rates and expanding healthcare access.

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Further, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it w...

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period. The new research study consists of industry trends, detailed market analysis, clinical trial analysis, likely drug candidates and market impact analysis, along with the market forecast and opportunity analysis. Currently, there are more than 1,000 cell and gene therapies under development, most of which are being d...

The global biohacking market, valued at USD 23.63 billion in 2024, is projected to reach USD 28.73 billion in 2025 and USD 137.37 billion by 2035, representing a CAGR of 16.9% during the forecast period. As more market players continue to accelerate innovation in this field, we believe the global biohacking industry will continue to expand at a steady rate during the forecast period.

The global women health app market, valued at USD 3.45 billion in 2024, is projected to reach USD 5.29 billion in 2025 and USD 27.00 billion by 2035, representing a CAGR of 17.7% during the forecast period. Presently menstrual health holds the highest share (34%) of the market. Smartphone segment holds 59% of the overall revenue share. North America contributed 39% of the revenue share. Based on the type of age group, the global market for women health app is distributed into 15 to 24 years, 25...

The medical disposables market is estimated to grow from USD 530.20 billion in 2024 to reach USD 611.15 billion in 2025 and USD 1974.30 billion by 2035, representing a higher CAGR of 12.4% during the forecast period. Presently, sterilization supplies segment holds 13% of the medical disposables market share. Sterilization supplies are essential to sterilize medical equipment and instrument that are consistently used for patient treatment.

The global non-invasive aesthetic treatment market is estimated to grow from USD 26.24 billion in 2024 to reach USD 30.22 billion in 2025 and USD 86.08 billion by 2035, representing a CAGR of 11.0% during the forecast period. Non-invasive aesthetic treatment industry is experiencing remarkable growth and stands to continue the expansion in upcoming years.

The smart implants market is estimated to grow from USD 5.23 billion in 2024 to reach USD 6.36 billion in 2025 and USD 30.34 billion by 2035, representing a higher CAGR of 16.9% during the forecast period. Notably, industrial players, such as Abbott, Medtronic, OrthoSensor, and VeraSense are at the forefront of technological innovations in this field.

The global biosimulation market size, valued at USD 3.45 billion in 2024, is projected to reach USD 4.18 billion in 2025 and USD 19.69 billion by 2035, representing a CAGR of 16.8% during the forecast period. According to our market report, presently the software segment occupies the highest biosimulation market share (62%), and the trend is likely to remain unchanged during the forecast period.

The global AI in mental health market, valued at USD 1.23 billion in 2024, is projected to reach USD 1.81 billion in 2025 and USD 27.77 billion by 2035, representing a CAGR of 31.4% during the forecast period. Owing to the increasing adoption of AI technologies in mental health, several market players have shown active interest in this field to develop advanced artificial intelligence-based solutions for patients with mental health conditions.

The global DNA test kits market, valued at USD 1.57 billion in 2024, is projected to reach USD 1.91 billion in 2025 and USD 9.20 billion by 2035, representing a CAGR of 17.0% during the forecast period. Given the ongoing demand, numerous industrial players are accelerating their strategic initiatives to develop advanced DNA test kits for faster analysis of mutations.

The global telestroke services market, valued at USD 1.89 billion in 2024, is projected to reach USD 2.18 billion in 2025 and USD 6.99 billion by 2035, representing a CAGR of 12.3% during the forecast period. Owing to the increasing demand for telestroke services, several industrial players have shown keen interest in this field. In order to expand global reach, presently market players are leveraging strategic partnerships and collaborations.

The global proton therapy systems market, valued at USD 1.49 billion in 2024, is projected to reach USD 1.66 billion in 2025 and USD 4.09 billion by 2035, representing a CAGR of 9.4% during the forecast period. Owing to the ongoing initiatives and expanding adoption of advanced therapies, it is expected that proton therapy systems market will continue to expand substantially during the forecast period.

The global animal genetics market size, valued at USD 6.89 billion in 2024, is expected to grow to USD 7.41 billion in 2025 and USD 13.45 billion by 2035, representing a CAGR of 6.1% during the forecast period. With availability of molecular technologies, such as next generation sequencing, CRISPR-Cas9, polymerase chain reaction and genome editing tools, researchers can significantly gain better insight on genes and modify them to develop a desired animal breed with high nutritional value. Furth...

The global immuno-oncology drugs market, valued at USD 80.82 billion in 2024, is projected to reach USD 97.52 billion in 2025 and USD 442.26 billion by 2035, representing a CAGR of 16.3% during the forecast period. Driven by the ongoing initiatives and accelerated approval, we believe that immuno-oncology drugs market will continue to grow at a steady pace during the forecast period.

The global optical coherence tomography market, valued at USD 1.74 billion in 2024, is projected to reach USD 1.95 billion in 2025 and USD 4.88 billion by 2035, representing a CAGR of 9.6% during the forecast period. Driven by the requirement of advanced optical coherence tomography, several industrial players are aiming for advancing cutting-edge technologies for faster and accurate diagnosis.